Reactions Weekly

, Volume 1695, Issue 1, pp 283–283 | Cite as

Nivolumab

Fatigue: case report
Case report
  • 13 Downloads

Reference

  1. Santin AD, et al. Regression of Chemotherapy-Resistant Polymerase epsilon (POLE) Ultra-Mutated and MSH6 Hyper-Mutated Endometrial Tumors with Nivolumab. Clinical cancer research: an official journal of the American Association for Cancer Research 22: 5682-5687, No. 23, Dec 2016 -USAGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations